bpc 157 healthline Injectable peptides such as BPC-157 are showing up more and more online—but what does the science say about them?, Dr. Michele Arthurs, a lifestyle medicine physician at Kaiser Permanente, explains BPC-157 Peptide Therapy Guide |

These reactions typically manifest as mild erythema, swelling, or tenderness at the injection site, usually resolving within 24-48 hours without intervention

Related: What is NAD

Neither agent individually holds MHRA marketing authorisation, and both remain in clinical development

Finally, targeting angiogenesis and NOs cytotoxic and damaging actions but maintaining, promoting, or recovering their essential protective functions [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] could indicate cytoprotective evidence that aligns with BPC 157 as a neurotransmitter, as previously envisaged in the implementation of the cytoprotection effects [6,9] (i.e., a cytoprotection mediator holds a response specifically related to preventing or recovering damage as such)

Mazdutide , developed by Innovent Biologics, is another GLP-1/glucagon dual agonist showing competitive weight loss results in Asian populations